Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2002;90:628-630
doi: 10.1161/01.RES.0000015402.38996.61
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Majesky, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Majesky, M. W.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Gene expression
Right arrow Gene regulation
Right arrow Genetically altered mice
Right arrow Smooth muscle proliferation and differentiation
(Circulation Research. 2002;90:628.)
© 2002 American Heart Association, Inc.


Editorials

Smooth Muscle-Specific Transcription Without a CArG Box Element

Mark W. Majesky

From the Departments of Pathology and Molecular and Cellular Biology, Center for Cardiovascular Development, Baylor College of Medicine, Houston, Tex.

Correspondence to Dr Mark W. Majesky, Dept of Pathology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030. E-mail mmajesky@bcm.tmc.edu


Key Words: smooth muscle • serum response factor • promoter • arterial injury

Studies of the transcriptional control of vascular smooth muscle-specific gene expression have highlighted the importance of a conserved DNA recognition element known as a CArG box. This element has the core sequence CC[AT]6GG and is the binding site for the central MADS box domain of the serum response factor (SRF). All smooth muscle cell (SMC)-specific promoter/enhancer elements characterized to date exhibit a strong dependence upon SRF binding to CArG elements located either in the 5' promoter region, the first intron, or both. It is therefore of considerable interest that a study by Layne et al1 found in this issue of Circulation Research reports the identification of regulatory elements from the mouse aortic carboxypeptidase-like protein (ACLP) promoter that drive reporter gene expression in transgenic mice in a vascular smooth muscle-specific pattern in the absence of a recognizable CArG element.

Mouse Aortic Carboxypeptidase-Like Protein

Mouse ACLP was discovered in a screen for human aortic proteins that interact with the basic helix-loop-helix (bHLH) domain of E47.2 E47, and its related family member E12, are heterodimeric binding partners for myogenic factors (MyoD and myogenin). Heterodimer formation is required for transcriptional activation by myogenic bHLH factors. One of the clones recovered in this screen was a truncated form of human ACLP, which was used to isolate a full-length clone. Sequence analysis of the full-length cDNA revealed that ACLP is a secreted protein that contains a discoidin I-like domain and a catalytically-inactive metallocarboxypeptidase domain. Proteins encoded by the truncated ACLP cDNA bound to E47, whereas full-length ACLP . . . [Full Text of this Article]